Pages that link to "Q73492611"
Jump to navigation
Jump to search
The following pages link to Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results (Q73492611):
Displaying 50 items.
- Rationale for and review of neoadjuvant therapy prior to radical prostatectomy for patients with high-risk prostate cancer (Q27028084) (← links)
- Early chemohormonal therapy in prostate cancer: preliminary data and randomized trials (Q30782065) (← links)
- Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer (Q31967563) (← links)
- Chemotherapy for hormone-refractory prostate cancer: beauty is in the eye of the beholder (Q34057806) (← links)
- Therapy‐associated effects in the prostate gland (Q34115527) (← links)
- Systemic treatment and new developments in advanced prostate cancer (Q34558153) (← links)
- Histologic changes associated with neoadjuvant chemotherapy are predictive of nodal metastases in patients with high-risk prostate cancer. (Q34618362) (← links)
- The evolving role of systemic therapy in high risk prostate cancer: strategies for cure in the 21st century (Q34635834) (← links)
- Novel therapies for the treatment of prostate cancer: current clinical trials and development strategies (Q34657935) (← links)
- Locally advanced prostate cancer (Q34677997) (← links)
- Highlights of contemporary issues in the medical management of prostate cancer (Q34793091) (← links)
- Chemotherapy for prostate cancer. (Q34856744) (← links)
- The multi-disciplinary management of high-risk prostate cancer (Q35014945) (← links)
- Neoadjuvant therapy for high-risk localized prostate cancer (Q35095383) (← links)
- Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints. (Q35156057) (← links)
- Management of high-risk localized prostate cancer: the integration of local and systemic therapy approaches (Q35156061) (← links)
- Prostate cancer: radical prostatectomy (Q35609537) (← links)
- Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease (Q35640625) (← links)
- Is there a role for chemotherapy in prostate cancer? (Q35776921) (← links)
- Neoadjuvant and adjuvant chemotherapy for high-risk localized prostate cancer (Q35876397) (← links)
- An interdisciplinary approach to treating prostate cancer (Q36153512) (← links)
- An update on randomized clinical trials in localized and locoregional prostate cancer (Q36194238) (← links)
- Management strategies for locally advanced prostate cancer (Q36421046) (← links)
- Surgery for locally advanced disease (Q36456154) (← links)
- The role of primary chemotherapy for prostate cancer: has the time come? (Q36456162) (← links)
- Neoadjuvant therapy before radical prostatectomy: where have we been? Where are we going? (Q36701418) (← links)
- Adjuvant and salvage treatment options for patients with high-risk prostate cancer treated with radical prostatectomy (Q36740128) (← links)
- Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer (Q36973569) (← links)
- Role of radical prostatectomy in the treatment of high-risk prostate cancer (Q37258850) (← links)
- Early chemotherapy in prostate cancer (Q37260272) (← links)
- Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer (Q37395384) (← links)
- Does chemotherapy have a role before hormone-resistant disease develops? (Q37446064) (← links)
- A systematic review of the role of adjuvant and neoadjuvant pharmacotherapy in patients undergoing radical prostatectomy (Q38014525) (← links)
- Neoadjuvant Chemotherapy prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer: A Systematic Review (Q38091071) (← links)
- Chemotherapy and novel therapeutics before radical prostatectomy for high-risk clinically localized prostate cancer (Q38321861) (← links)
- Role of systematic ultrasound-guided staging biopsies in predicting extraprostatic extension and seminal vesicle invasion in men with prostate cancer (Q39599470) (← links)
- Preoperative Clinical and Pathological Characteristics of pT0 Prostate Cancer in Radical Prostatectomy (Q41304862) (← links)
- A new therapy paradigm for prostate cancer founded on clinical observations (Q41871408) (← links)
- Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification (Q42400390) (← links)
- Distinguishing Atrophy and High-Grade Prostatic Intraepithelial Neoplasia From Prostatic Adenocarcinoma With and Without Previous Adjuvant Hormone Therapy With the Aid of Cytokeratin 5/6 (Q42450444) (← links)
- Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer. (Q44387038) (← links)
- Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer (Q44926809) (← links)
- Neoadjuvant chemohormonal therapy in poor-prognosis localized prostate cancer (Q46727863) (← links)
- Therapeutic strategies for localized prostate cancer. (Q50249555) (← links)
- Advances in prostate cancer treatment: highlights from the 2nd international prostate cancer congress, st. Thomas, u.s. Virgin islands, july 17-20, 2002. (Q53249559) (← links)
- The addition of chemotherapy in the definitive management of high risk prostate cancer (Q57482000) (← links)
- Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer (Q77359717) (← links)
- [Significance of neoadjuvant therapy before radical prostatectomy] (Q80098813) (← links)
- Initial experience with single-agent docetaxel as neoadjuvant therapy in men with locally advanced prostate cancer (Q80297714) (← links)
- Neoadjuvant Therapy for Prostate Cancer: An Oncologist's Perspective (Q80297720) (← links)